Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Aminoquinoline Derivatives Significantly Reduce Parasite Load in Leishmania infantum Infected Mice
Jelena Konstantinović, Milica Videnović, Stefania Orsini, et al.
ACS Medicinal Chemistry Letters (2018) Vol. 9, Iss. 7, pp. 629-634
Open Access | Times Cited: 11

Showing 11 citing articles:

Quinolines and Quinolones as Antibacterial, Antifungal, Anti-virulence, Antiviral and Anti-parasitic Agents
Lidija Šenerović, Dejan Opsenica, Ivana Morić, et al.
Advances in experimental medicine and biology (2019), pp. 37-69
Open Access | Times Cited: 86
4-Aminoquinoline as a privileged scaffold for the design of leishmanicidal agents: structure–property relationships and key biological targets
Angel H. Romero, Francisco Delgado
Frontiers in Chemistry (2025) Vol. 12
Open Access
Quinoline: A Promising Scaffold in Recent Antiprotozoal Drug Discovery
Atukuri Dorababu
ChemistrySelect (2021) Vol. 6, Iss. 9, pp. 2164-2177
Closed Access | Times Cited: 39
New antileishmanial quinoline linked isatin derivatives targeting DHFR-TS and PTR1: Design, synthesis, and molecular modeling studies
Ahmed Sabt, Wagdy M. Eldehna, Tamer M. Ibrahim, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114959-114959
Closed Access | Times Cited: 21
Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial Activity
Cyril Fersing, Louise Basmaciyan, Clotilde Boudot, et al.
ACS Medicinal Chemistry Letters (2018) Vol. 10, Iss. 1, pp. 34-39
Open Access | Times Cited: 39
4-Aminoquinoline-Based Adamantanes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer’s Disease
Katarina Komatović, Ana Matošević, Nataša Terzić, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1305-1305
Open Access | Times Cited: 13
Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents
Alexandra Ioana Corfu, Nuno Santarém, Sara Luelmo, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 6, pp. 2222-2238
Open Access | Times Cited: 1
4-Aminoquinoline-based compounds as antileishmanial agents that inhibit the energy metabolism of Leishmania
José Ignacio Manzano, Jelena Konstantinović, Diletta Scaccabarozzi, et al.
European Journal of Medicinal Chemistry (2019) Vol. 180, pp. 28-40
Closed Access | Times Cited: 12
Novel Hydrophilic Riminophenazines as Potent Antiprotozoal Agents
Ivan Bassanini, Silvia Parapini, Nicoletta Basilico, et al.
ChemMedChem (2019) Vol. 14, Iss. 22, pp. 1940-1949
Closed Access | Times Cited: 11
Quinolizidine-Derived Lucanthone and Amitriptyline Analogues Endowed with Potent Antileishmanial Activity
Michele Tonelli, Anna Sparatore, Nicoletta Basilico, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 11, pp. 339-339
Open Access | Times Cited: 7
Targeting Kinetoplastid and Apicomplexan Thymidylate Biosynthesis as an Antiprotozoal Strategy
María Valente, Antonio E. Vidal, Dolores González‐Pacanowska
Current Medicinal Chemistry (2018) Vol. 26, Iss. 22, pp. 4262-4279
Closed Access | Times Cited: 5
15.4.5 Quinolinones and Related Systems (Update 2022)
Vera L. M. Silva, Diana C. G. A. Pinto, Clementina M.M. Santos, et al.
(2022)
Closed Access
Page 1

Scroll to top